Parallel (randomized) phase II evaluation of tivantinib (ARQ197) and tivantinib in combination with erlotinib in papillary renal cell carcinoma: SWOG S1107
Przemyslaw W. Twardowski, Catherine M. Tangen, Xiwei Wu, Melissa R. Plets, Elizabeth R. Plimack, Neeraj Agarwal, Nicholas J. Vogelzang, Jinhui Wang, Shu Tao, Ian M. Thompson, Primo Lara
Research output: Contribution to journal › Article › peer-review
30Scopus
citations
Fingerprint
Dive into the research topics of 'Parallel (randomized) phase II evaluation of tivantinib (ARQ197) and tivantinib in combination with erlotinib in papillary renal cell carcinoma: SWOG S1107'. Together they form a unique fingerprint.